GM
65
-3
COP
56
2
PSA
51
-4
IR
63
3
RRC
63
3
COF
55
-3
NWSA
62
2
DD
56
3
IVZ
46
3
LUV
39
-5
LB
34
8
K
53
2
APA
21
2
CSX
51
-2
INTC
35
-2
MPC
47
3
AIV
68
-4
VRTX
46
2
C
58
-2
EW
37
-2
GM
65
-3
COP
56
2
PSA
51
-4
IR
63
3
RRC
63
3
COF
55
-3
NWSA
62
2
DD
56
3
IVZ
46
3
LUV
39
-5
LB
34
8
K
53
2
APA
21
2
CSX
51
-2
INTC
35
-2
MPC
47
3
AIV
68
-4
VRTX
46
2
C
58
-2
EW
37
-2
Financhill
Back

Knightscope 10K Form

Buy
56

KSCP
Knightscope

Last Price:
16.24
Seasonality Move:
-35.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KSCP News And Ratings

See the #1 stock for the next 7 days that we like better than KSCP

KSCP Financial Statistics

Sales & Book Value

Annual Sales: $12.8M
Cash Flow: $-4.04M
Price / Cash Flow: 0
Annual Sales: $4.18
Price / Book: 4.03

Profitability

EPS (TTM): -16.00000
Net Income (TTM): $-28.74M
Gross Margin: $-2.02M
Return on Equity: -323.06%
Return on Assets: -118.05%

Knightscope Earnings Forecast

Key Knightscope Financial Ratios

  • The Gross Profit Margin over the past 5 years for KSCP is -15.82%.
  • The Selling, General & Administrative Expenses for KSCP have been equal to 138.81% of Gross Profit Margin.
  • The Research & Development expenses have been 49.63% of Revenue.
  • The Interest Expense is -2.49% of Operating Income.
  • The Net Earning history of KSCP is -172.84% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Knightscope Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial Services & Supplies
Sector: Industrials
Current Symbol: KSCP
Website: knightscope.com

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 1.21
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KSCP Technical Analysis vs Fundamental Analysis

Buy
56
Knightscope (KSCP) is a Buy

Is Knightscope a Buy or a Sell?

  • Knightscope stock is rated a Buy
    The current Knightscope [KSCP] share price is $16.19. The Score for KSCP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.